메뉴 건너뛰기




Volumn 50, Issue 6, 2016, Pages 710-717

Adaptive Design Practice at the Center for Devices and Radiological Health (CDRH), January 2007 to May 2013

Author keywords

adaptive design; FDA; medical device; survey

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); FOOD AND DRUG ADMINISTRATION; FREQUENTIST; HUMAN; MEDICAL DEVICE; PLANNING; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL; STUDY DESIGN; UNITED STATES;

EID: 84992453953     PISSN: 21684790     EISSN: 21684804     Source Type: Journal    
DOI: 10.1177/2168479016656027     Document Type: Article
Times cited : (10)

References (22)
  • 2
    • 0017744944 scopus 로고
    • Group sequential methods in the design and analysis of clinical trials
    • Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika. 1977;64:191–199.
    • (1977) Biometrika , vol.64 , pp. 191-199
    • Pocock, S.J.1
  • 3
    • 0018687930 scopus 로고
    • A multiple testing procedure for clinical trials
    • O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549–556.
    • (1979) Biometrics , vol.35 , pp. 549-556
    • O’Brien, P.C.1    Fleming, T.R.2
  • 4
    • 0024401563 scopus 로고
    • Group sequential procedures: calendar versus information time
    • Lan KKG, DeMets DL. Group sequential procedures: calendar versus information time. Stat Med. 1987;8:1191–1198.
    • (1987) Stat Med , vol.8 , pp. 1191-1198
    • Lan, K.K.G.1    DeMets, D.L.2
  • 5
    • 0029589385 scopus 로고
    • Designed extension of studies based on conditional power
    • Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics. 1995;51:1315–1324.
    • (1995) Biometrics , vol.51 , pp. 1315-1324
    • Proschan, M.A.1    Hunsberger, S.A.2
  • 6
    • 0032886394 scopus 로고    scopus 로고
    • Modification of sample size in group sequential clinical trials
    • Cui L, Hung HM, Wang S. Modification of sample size in group sequential clinical trials. Biometrics. 1999;55:853–857.
    • (1999) Biometrics , vol.55 , pp. 853-857
    • Cui, L.1    Hung, H.M.2    Wang, S.3
  • 7
    • 0034876356 scopus 로고    scopus 로고
    • Adaptive group sequential designs for clinical trials: Combining the advantages of adaptive and of classical group sequential approaches
    • Müller H, Schäfer H. Adaptive group sequential designs for clinical trials: Combining the advantages of adaptive and of classical group sequential approaches. Biometrics. 2001;57:886–891.
    • (2001) Biometrics , vol.57 , pp. 886-891
    • Müller, H.1    Schäfer, H.2
  • 8
    • 1842730273 scopus 로고    scopus 로고
    • Increasing the sample size when the unblinded interim result is promising
    • Chen YHJ, DeMets DL, Lan KKG. Increasing the sample size when the unblinded interim result is promising. Stat Med. 2004;23:1023–1038.
    • (2004) Stat Med , vol.23 , pp. 1023-1038
    • Chen, Y.H.J.1    DeMets, D.L.2    Lan, K.K.G.3
  • 9
    • 57349108084 scopus 로고    scopus 로고
    • Sample size re-estimation for adaptive sequential design in clinical trials
    • Gao P, Ware JH, Mehta C. Sample size re-estimation for adaptive sequential design in clinical trials. J Biopharm Stat. 2008;18:1184–1196.
    • (2008) J Biopharm Stat , vol.18 , pp. 1184-1196
    • Gao, P.1    Ware, J.H.2    Mehta, C.3
  • 11
    • 84889662412 scopus 로고    scopus 로고
    • Similarities and differences of Bayesian designs and adaptive designs for medical devices: a regulatory view
    • Campbell G. Similarities and differences of Bayesian designs and adaptive designs for medical devices: a regulatory view. Stat Biopharm Res. 2013;5:356–368.
    • (2013) Stat Biopharm Res , vol.5 , pp. 356-368
    • Campbell, G.1
  • 13
    • 84907946289 scopus 로고    scopus 로고
    • Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
    • Elsäßer A, Regnstrom J, Vetter T. Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency. Trials. 2014;15:383.
    • (2014) Trials , vol.15 , pp. 383
    • Elsäßer, A.1    Regnstrom, J.2    Vetter, T.3
  • 15
    • 0035961473 scopus 로고    scopus 로고
    • Sample size re-estimation—journey for a decade
    • Shih W. Sample size re-estimation—journey for a decade. Stat Med. 2001;20:515–518.
    • (2001) Stat Med , vol.20 , pp. 515-518
    • Shih, W.1
  • 18
    • 37549067785 scopus 로고    scopus 로고
    • Experience with reviewing Bayesian medical device trials
    • Pennello G, Thompson L. Experience with reviewing Bayesian medical device trials. J Biopharm Stat. 2008;18:81–115.
    • (2008) J Biopharm Stat , vol.18 , pp. 81-115
    • Pennello, G.1    Thompson, L.2
  • 19
    • 80051730237 scopus 로고    scopus 로고
    • Bayesian statistics in medical devices: innovation sparked by the FDA
    • Campbell G. Bayesian statistics in medical devices: innovation sparked by the FDA. J Biopharm Stat. 2011;21:871–887.
    • (2011) J Biopharm Stat , vol.21 , pp. 871-887
    • Campbell, G.1
  • 20
    • 77950189829 scopus 로고    scopus 로고
    • CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
    • Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
    • (2010) BMJ , vol.340 , pp. c332
    • Schulz, K.F.1    Altman, D.G.2    Moher, D.3
  • 21
    • 77950273246 scopus 로고    scopus 로고
    • CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
    • Moher D, Hopewell S, Schulz F. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
    • (2010) BMJ , vol.340 , pp. c869
    • Moher, D.1    Hopewell, S.2    Schulz, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.